ArticleClinical transplantation2023

Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation.

Joseph B Lerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.